These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27776961)

  • 1. Early and recurrent macular oedema in a patient treated with fingolimod.
    Cifuentes-Canorea P; Nieves-Moreno M; Sáenz-Francés F; Santos-Bueso E
    Neurologia (Engl Ed); 2019 Apr; 34(3):206-207. PubMed ID: 27776961
    [No Abstract]   [Full Text] [Related]  

  • 2. Fingolimod-associated macular oedema.
    Jasani KM; Sharaf N; Rog D; Aslam T
    BMJ Case Rep; 2017 Jun; 2017():. PubMed ID: 28619738
    [No Abstract]   [Full Text] [Related]  

  • 3. Longitudinal quantitative assessment of macula during therapy with fingolimod in relapsing-remitting multiple sclerosis.
    Fruschelli M; Capozzoli M; Gelmi MC; Masi G; Annunziata P
    Int Ophthalmol; 2019 Apr; 39(4):777-781. PubMed ID: 29500696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world incidence of fingolimod-associated macular oedema.
    Goh LY; Kirthi V; Silber E; Harvey JP; Jackson TL
    Mult Scler Relat Disord; 2020 Jul; 42():102125. PubMed ID: 32403070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Famous.
    Kim MJ; Bhatti MT; Costello F
    Surv Ophthalmol; 2016; 61(4):512-9. PubMed ID: 26742785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetazolamide therapy in a case of fingolimod-associated macular edema: early benefits and long-term limitations.
    Schröder K; Finis D; Harmel J; Ringelstein M; Hartung HP; Geerling G; Aktas O; Guthoff R
    Mult Scler Relat Disord; 2015 Sep; 4(5):406-408. PubMed ID: 26346788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does fingolimod in multiple sclerosis patients cause macular edema?
    Turaka K; Bryan JS
    J Neurol; 2012 Feb; 259(2):386-8. PubMed ID: 22231867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of macular edema without discontinuation of fingolimod in a patient with multiple sclerosis: A case report.
    Akiyama H; Suzuki Y; Hara D; Shinohara K; Ogura H; Akamatsu M; Hasegawa Y
    Medicine (Baltimore); 2016 Jul; 95(29):e4180. PubMed ID: 27442641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy.
    Laroni A; Brogi D; Brescia Morra V; Guidi L; Pozzilli C; Comi G; Lugaresi A; Turrini R; Raimondi D; Uccelli A; Mancardi GL
    Neurol Sci; 2017 Jan; 38(1):53-59. PubMed ID: 27757552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis.
    Christopher KL; Elner VM; Demirci H
    Ophthalmic Plast Reconstr Surg; 2017; 33(3):e73-e75. PubMed ID: 27533512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Merkel cell carcinoma in a patient with relapsing-remitting multiple sclerosis treated with fingolimod.
    Calvi A; De Riz M; Lecchi E; Pietroboni A; Ghezzi L; Scarioni M; Carandini T; Pellegrinelli A; Maurichi A; Galimberti D; Scarpini E
    J Neurol Sci; 2017 Oct; 381():296-297. PubMed ID: 28991701
    [No Abstract]   [Full Text] [Related]  

  • 12. Retinal hemorrhages following fingolimod treatment for multiple sclerosis; a case report.
    Ueda N; Saida K
    BMC Ophthalmol; 2015 Oct; 15():135. PubMed ID: 26481728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative cystoid macular oedema in a patient on fingolimod.
    Gaskin JC; Coote M
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25969500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fingolimod Associated Bilateral Cystoid Macular Edema-Wait and See?
    Pul R; Osmanovic A; Schmalstieg H; Pielen A; Pars K; Schwenkenbecher P; Sühs KW; Yildiz Ö; Frank B; Stangel M; Skripuletz T
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27983657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi sarcoma in a fingolimod-treated patient with multiple sclerosis.
    Walker S; Brew B
    J Clin Neurosci; 2016 Sep; 31():217-8. PubMed ID: 27168454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive cutaneous leishmaniasis in a patient with multiple sclerosis treated with fingolimod.
    Hernández Clares R; Sánchez Pedreño P; García Vazquez E; Carreón Guarnizo E; Meca Lallana JE
    Neurologia (Engl Ed); 2018 Jun; 33(5):348-349. PubMed ID: 28535923
    [No Abstract]   [Full Text] [Related]  

  • 17. Macular oedema and changes in macular thickness in multiple sclerosis patients treated with fingolimod.
    Nørgaard TL; Andersen CU; Hilt C; Andersen CU
    Basic Clin Pharmacol Toxicol; 2020 Jun; 126(6):492-497. PubMed ID: 31880065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fingolimod-associated macular edema: resolution by sub-tenon injection of triamcinolone with continued fingolimod use.
    Minuk A; Belliveau MJ; Almeida DR; Dorrepaal SJ; Gale JS
    JAMA Ophthalmol; 2013 Jun; 131(6):802-4. PubMed ID: 23599188
    [No Abstract]   [Full Text] [Related]  

  • 19. [Switching therapy from natalizumab to fingolimod: reduction of the washout time?].
    Sánchez-Gundín J; Flor García A; Martí Gil C; Gómez Romero L
    Farm Hosp; 2015 Sep; 39(5):314-5. PubMed ID: 26546944
    [No Abstract]   [Full Text] [Related]  

  • 20. [Early onset of fingolimod-associated macular edema].
    Schelenz D; Kleiter I; Schöllhammer J; Rehrmann J; Elling M; Dick HB; Kakkassery V
    Ophthalmologe; 2018 May; 115(5):424-428. PubMed ID: 28653209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.